Flemington Pharmaceutical Corporation Announces Patent Issuance.FLEMINGTON, N.J.--(BUSINESS WIRE)--Dec. 13, 1999-- Flemington Pharmaceutical Corp. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:FLEM) (OTC BB:FLEMw) (Flemington or the Company) announced today that it had been issued United States Patent No. 5,955,098 for its validated Immediate-Immediate Release (I2R I2R Institute for Infocomm Research I2R Imaging Infrared )(tm) lingual lingual /lin·gual/ (ling´gwal) 1. pertaining to or near the tongue. 2. in dental anatomy, facing the tongue or oral cavity. lin·gual adj. 1. spray delivery system for the administration of antihistamines Antihistamines Definition Antihistamines are drugs that block the action of histamine (a compound released in allergic inflammatory reactions) at the H1 , steroid hormones, non-steroidal anti-inflammatories, alkaloids alkaloids, n alkaline phytochemicals that contain nitrogen in a heterocyclic ring structure. They can have powerful pharmacological effects and are more often used in traditional medicine than in herbal treatments. , benzodiazepines Benzodiazepines Definition Benzodiazepines are medicines that help relieve nervousness, tension, and other symptoms by slowing the central nervous system. Purpose Benzodiazepines are a type of antianxiety drugs. , analgesics and anti-depressants. The patent covers the delivery of these classes of drugs in non-polar solvents. Dr. Harry A. Dugger III, President of the Company stated that, in his opinion, the pilot studies already carried out by the Company on nicotine and estradiol have verified the ability of the Company's lingual spray delivery system to deliver theraputic levels of medication to the body rapidly and at lower dosages. Flemington is engaged in the development of novel drug delivery systems for presently marketed prescription and over-the-counter drugs. The novel delivery systems include lingual sprays and soft gelatin gelatin or animal jelly, foodstuff obtained from connective tissue (found in hoofs, bones, tendons, ligaments, and cartilage) of vertebrate animals by the action of boiling water or dilute acid. bite capsules. The Company believes these delivery systems offer (I) improved drug safety by reducing the required dosage, therefore reducing side effects; (II) improved dosage reliability; (III) improved patient convenience and compliance; and (IV) enhanced dosage reliability. The Company plans to develop such products through collaborative arrangements with major pharmaceutical companies. For further information visit the Company's Web site: www.flemington-pharma.com NOTE: Except for historical information contained herein, this document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such statements may involve known and unknown risks and uncertainties that may cause the Company's actual results and outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Important factors that the Company believes might cause such differences are discussed in the various risk factors detailed in the Company's most recent Form 10-KSB, dated Oct. 28, 1998, filed with the Securities and Exchange Commission; a copy of that Form 10-KSB is available from the Company, upon request. In assessing forward-looking statements contained herein, if any, readers are urged to read carefully all cautionary statements contained in that filing with the Securities and Exchange Commission. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion